Knowledge Center

Membership Resources


Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.

After making your filter selections, please scroll down to see results.

Filters
Clear All
Results 182
Articles

The Effects of Testosterone Therapy in Females on Lipid Parameters and Cardiovascular Disease Risk

In a systematic review and meta-analysis of 29 trials with moderate risk of bias, Maraka S. et al summarized the effect of sex hormone therapy…

Read More |
Articles

Case Study: Type 1 Diabetes, Familial Hypercholesterolemia, and Elevated Lipoprotein(a)

Familial hypercholesterolemia (FH) and type 1 diabetes (T1D) are characterized by significant morbidity and premature mortality. Lipoprotein(a) [Lp(a)], an independent cardiovascular disease (CVD) risk factor,…

Read More |
Articles

Motivation from Failure

Imagine the following scenario: Your patient presents for a routine follow-up appointment. As you review the chart you realize the labs, blood pressure, and/or weight…

Read More |
Articles

Statins and Brain Fog: Confusing for Patients, Prescribers, and Me

HMG-CoA reductase inhibitors (statins) were FDA-approved in 1987 and their introduction has revolutionized lipid and cardiovascular (CV) management for the past three decades. Despite this,…

Read More |
Articles

Elevated and Dysfunctional HDL

High density lipoprotein (HDL) has long been known as a negative risk factor for the development of atherosclerosis and cardiovascular disease. The traditional explanation of…

Read More |
Articles

Icosapent Ethyl-Treated Hypertriglyceridemia to Reduce ASCVD Residual Risk

The Reduction of Cardiovascular Events with Icosapent Ethyl Intervention Trial (REDUCE-IT) as authored by Bhatt, DL et al, shows strong evidence that icosapent ethyl, in…

Read More |
Articles

The Unique South Asian Phenotype and Opportunities for Early Intervention to Prevent Diabetes and ASCVD

There are close to 4 million SAs living in North America (2.84 million in the US). Lipid abnormalities in SAs are closely intertwined with insulin…

Read More |
Articles

Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association

There is clinical utility of genetic testing for familial hypercholesterolemia, familial chylomicronemia syndrome, sitosterolemia, lysosomal acid lipase deficiency, and a few other rare disorders, and…

Read More |